ಟ್ವೀಟ್ಗಳು
- ಟ್ವೀಟ್ಗಳು
- ಟ್ವೀಟ್ಗಳು & ಪ್ರತಿಕ್ರಿಯೆಗಳು
- ಮಾಧ್ಯಮ
@FinneganIPLaw ತಡೆಹಿಡಿಯಲಾಗಿದೆ
ನೀವು ಖಚಿತವಾಗಿಯೂ ಈ ಟ್ವೀಟ್ಗಳನ್ನು ನೋಡಲು ಬಯಸುವಿರಾ? ಟ್ವೀಟ್ಗಳನ್ನು ನೋಡುವುದು @FinneganIPLaw ಅವರನ್ನು ತಡೆತೆರವುಗೊಳಿಸುವುದಿಲ್ಲ.
-
Join our Boston office for a discussion & celebration of the past year's key
#IP trends in#FederalCircuit#caselaw http://bit.ly/2iMNOBH pic.twitter.com/zq4zKLKyUr
-
Graphical Indicator Patent Gets “Definite” Win Under § 112 http://bit.ly/2jluI4K pic.twitter.com/rGfH8f4Ip7
-
Aaron Parker and Justin Hendrix will discuss
#medicaldevice innovation at the@Opal_Group Medical Devices Summit http://bit.ly/2iJpWBL -
Eric Raciti, Jessica Marks & Drew Christie on Where Equivalence Isn’t Equivalent: Using 510(k)s in
#PatentLitigation http://bit.ly/2i1BSgK -
Aaron Parker & Amy Hsaio on 3 Take-aways From Michael Jordan’s Chinese Supreme Court
#Trademark Victory http://bit.ly/2hTKQu5 -
Protests: Are Those Still Around? http://bit.ly/2hXtxuC pic.twitter.com/Wgviu6B8ga
-
Procedural Missteps Lead to Default Judgment http://bit.ly/2j90GBd pic.twitter.com/lppmWpCDGh
-
Procedural Missteps Lead to Default Judgment http://bit.ly/2j90GBd pic.twitter.com/wd7AFhb5DM
-
Finnegan is a sponsor of the Ort Binyamia High School
#Robotics Team in the@FIRSTweets#FRCrobotics Competition http://bit.ly/2h4YLAY -
#ProsecutionPointer Check current estimates on how long it will take for a 1st office action on a patent application http://bit.ly/2hTxsZh pic.twitter.com/Xfn3dCjuy1
-
Don Dunner & Erika Arner will present at the
@COBarAssoc National#CLE Conference#IP Program in Snowmass, Colorado http://bit.ly/2ixfXfH -
Summary of FDA Clinical Pharmacology Guidance for Demonstrating
#Biosimilarity http://bit.ly/2iI9H7G pic.twitter.com/E9xnqBzgtC
-
Finnegan IP Marketplace Newsletter - December 2016 http://bit.ly/2hAHXk8 pic.twitter.com/vbWdNrgZu6
-
IPR and CBM Statistics for Final Written Decisions Issued in November 2016 http://bit.ly/2hUlHiK pic.twitter.com/Xe07DM4gOM
-
3 Take-aways From Michael Jordan’s Chinese Supreme Court Trademark Victory For Companies Doing Business In China http://bit.ly/2hTKQu5
-
Part I (of II):
#FederalCircuit Trends of 2016 http://bit.ly/2hzIwfE pic.twitter.com/t8fpxVsgL4
-
Change in Law Does Not Always Compel Remand http://bit.ly/2iigXak pic.twitter.com/UdHltpMQkO
-
Now available: The Second Edition of Global Patent Litigation Treatise by Finnegan attorneys http://bit.ly/2ijOiO7 pic.twitter.com/4EJB9spCeq
-
#PTAB: What to Expect on Remand http://bit.ly/2hgsA1J pic.twitter.com/HOlU6RYHiX
-
#ProsecutionPointer Cooperative Patent Classification (CPC) codes can be found... http://bit.ly/2ifWMpB pic.twitter.com/NapfA0NdrT
Finnegan
ಲೋಡಿಂಗ್ ಸಮಯ ಸ್ವಲ್ಪ ತೆಗೆದುಕೊಳ್ಳುತ್ತಿರುವಂತೆನಿಸುತ್ತದೆ.
Twitter ಸಾಮರ್ಥ್ಯ ಮೀರಿರಬಹುದು ಅಥವಾ ಕ್ಷಣಿಕವಾದ ತೊಂದರೆಯನ್ನು ಅನುಭವಿಸುತ್ತಿರಬಹುದು. ಮತ್ತೆ ಪ್ರಯತ್ನಿಸಿ ಅಥವಾ ಹೆಚ್ಚಿನ ಮಾಹಿತಿಗೆ Twitter ಸ್ಥಿತಿಗೆ ಭೇಟಿ ನೀಡಿ.